معرفی
Alain Schoepfer is an Associate Professor at the University of Lausanne (UNIL), affiliated with the Faculty of Biology and Medicine, and Head of the Outpatient Department in the Gastroenterology and Hepatology Department at the Lausanne University Hospital (CHUV). He is internationally recognized for his research on inflammatory bowel diseases, particularly eosinophilic esophagitis (EoE).
His research interests focus on inflammatory bowel diseases, eosinophilic esophagitis, and the development of clinical scoring systems to assess disease activity. He founded and leads the international Eosinophilic Esophagitis Activity Index (EEsAI) group, which developed the first validated PRO instrument for EoE, widely used in clinical trials. His work also includes participation in the Swiss IBD Cohort Study and leadership of the Swiss Eosinophilic Esophagitis Cohort. He has contributed to the standardization of disease measurement and evaluation of novel therapies in gastroenterology.
Alain Schoepfer has received notable recognition for his contributions, including:
- Honorary Prize of the Swiss Society of Gastroenterology (2014)
- Allergy Prize of the Swiss Society of Allergy and Immunology (2016)
He is actively involved in postgraduate medical education, patient information initiatives, and the development of national and international clinical guidelines in gastroenterology. He supervises clinical training and contributes to academic mentorship, though no specific students are listed in the source material. He has no listed publications in the provided text, but his research output is extensive and influential in the field of digestive diseases.
